Q4 2024 Earnings Call Transcript February 27, 2025 GoodRx Holdings, Inc. misses on earnings expectations. Reported EPS is $0.09 EPS, expectations were $0.1. Operator: Ladies and gentlemen, thank you ...

Operator Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx fourth-quarter and full-year 2024 earnings call. As a reminder, today's call is being recorded. I would now like to ...

Before you buy stock in GoodRx, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and GoodRx wasn’t ...

GoodRx makes it easy for people to save time ... we believe that we provide an extremely strong value proposition to brand team. Second, we want to help pharmacies improve profitability and ...

GoodRx Holdings, Inc. (NASDAQ ... we’re talking about a 10,000% gain over the next decade! Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Tiffany Meng, PharmD, an oncology pharmacist, UCSF Health, discusses how pharmacists help mitigate financial toxicity for ...

Celigo, the leading Integration Platform as a Service (iPaaS) provider, today announced that George Mogannam has joined the company as Chief Revenue Officer (CRO). In this role, Mogannam will be ...

Amperity, an AI-powered customer data cloud, today announced the appointment of Dawn G. Lepore as Chairman of its Board of Directors. Lepore, a seasoned technology executive and former CEO of ...

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...